par Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Rebecca;Lodwick, Dominique;Costagliola, Peter;Reiss, Carlo;Torti, Ramón;Teira, Maria;Dorrucci, Bruno;Ledergerber, Amanda;Mocroft, Daniel;Podzamczer, Alessandro;Cozzi-Lepri, Niels;Obel, Bernard;Masquelier, Schlomo;Staszewski, Federico;Garcia Colominas, Stéphane ;De Wit, Antonella ;Castagna, Andrea;Antinori, Ali;Judd, Jade;Ghosn, Giota;Touloumi, Cristina;Mussini, Xavier;Duval, José;Ramos, Laurence;Meyer, Josiane;Warsawski, Claire;Thorne, Joan;Masip, Santiago;Pérez-Hoyos, Deenan;Pillay, Ard;van Sighem, Sergio;Lo Caputo, Huldrych;Günthard, Roger;Paredes, Andrea;De Luca, Dimitrios;Paraskevis, Céline;Fabre-Colin, Jesper;Kjaer, Geneviève;Chêne, Jens D;Lundgren, Andrew N.;Phillips,
Référence Archives of internal medicine, 170, 5, page (410-419)
Publication Publié, 2010-03
Référence Archives of internal medicine, 170, 5, page (410-419)
Publication Publié, 2010-03
Article révisé par les pairs
Résumé : | Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to approach that of the general population in some successfully treated subgroups. However, to attain these life expectancies, viral suppression must be maintained for decades. |